Overweight and obesity: pharmacotherapeutic considerations

Area of Science:

• Clinical Medicine
• Pharmacology
• Public Health

Background:

• Overweight and obesity are epidemic in the United States, posing significant risks for morbidity and mortality across all age groups.
• Obesity is a complex health issue requiring multifaceted management strategies.
• Primary care providers need current knowledge on pharmacologic interventions for obesity.

Purpose of the Study:

• To review current trends in using pharmacotherapy alongside other weight loss modalities.
• To provide clinical considerations for healthcare providers regarding weight loss pharmacotherapy.

Main Methods:

• Review of selected evidence-based articles.
• Consultation of government websites for relevant data and guidelines.

Main Results:

• Pharmacotherapy for weight management in overweight, obese, and extremely obese individuals remains a subject of debate.
• The balance of risk versus benefit and the safety profile of prescription weight loss drugs are key considerations.

Conclusions:

• The use of pharmacotherapy in obesity management requires careful evaluation of individual patient profiles.
• Further evidence-based outcomes research is needed to solidify the role of pharmacotherapy in long-term weight management.
• Clinicians play a critical role in navigating the complexities of pharmacologic obesity treatment.